REVLON INC-CLASS A (REV)

US7615256093 - Common Stock

3.8999  -0.22 (-5.34%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

REVLON INC-CLASS A

NYSE:REV (10/20/2022, 7:11:10 PM)

3.8999

-0.22 (-5.34%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap228.40M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

REV Daily chart

Company Profile

Revlon, Inc. manufactures and sells beauty and personal care products. The company is headquartered in New York City, New York and currently employs 5,800 full-time employees. The firm develops, manufactures, markets, distributes and sells an array of beauty and personal care products. The company operates through four segments: Revlon segment is comprised of the Company's flagship Revlon branded products, which are primarily marketed, distributed and sold in the retail channel, chain drug and food stores, chemist shops, hypermarkets, e-commerce sites, television shopping, department stores, hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores; Elizabeth Arden segment is comprised of its Elizabeth Arden branded products; Portfolio segment markets, distributes and sells a comprehensive line of products primarily to the retail channel, hair and nail salons and salon distributors; Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances, as well as the distribution of prestige fragrance brands owned by third parties.

Company Info

REVLON INC-CLASS A

One New York Plaza

New York City NEW YORK 10004

P: 12125274000.0

CEO: Debra G. Perelman

Employees: 5800

Website: https://www.revlon.com/

REV News

News Imagea year ago - RevlonRevlon Reports Fourth Quarter 2022 Results
News Imagea year ago - InvestorPlace25 Penny Stocks to Sell Before They Die

Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.

News Imagea year ago - RevlonRevlon Reports Third Quarter 2022 Results
News Imagea year ago - InvestorPlaceArrival (ARVL) Stock Plunges 30% on Bankruptcy Fears

British EV startup Arrival may be on the verge of bankruptcy. Here's what investors need to know about ARVL stock.

News Image2 years ago - InvestorPlaceVeris Residential (VRE) Stock Soars 18% on Buyout Offer

Veris Residential (VRE) stock is rising higher on Friday after the company received a buyout offer from Kushner Companies.

News Image2 years ago - InvestorPlaceWhy Is Immunic (IMUX) Stock Down 76% Today?

Immunic (IMUX) stock is plummeting on Friday after the company reported a high placebo rate in a Phase 1b clinical trial.

REV Twits

Here you can normally see the latest stock twits on REV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example